Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anabelle Brocard

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Dermatology : EJD|November 7, 2013
Severe radiotherapy-induced extracutaneous toxicity under vemurafenibLucie Peuvrel, Anne-Lise Ruellan, François Thillays, et al.
Acta Dermato-Venereologica|May 9, 2014
Vorinostat for refractory or relapsing epidermotropic T-cell lymphoma: a retrospective cohort study of 15 patientsAnne Kogge, Christelle Volteau, Mélanie Saint-Jean, et al.
European Journal of Dermatology : EJD|August 23, 2013
Atypical cutaneous vasculitis under lapatinibLucie Peuvrel, Gaëlle Quereux, Anabelle Brocard, et al.
Journal of the American Academy of Dermatology|September 18, 2013
Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literatureGaelle Quéreux, Anabelle Brocard, Mélanie Saint-Jean, et al.
European Journal of Dermatology : EJD|August 6, 2015
Phototoxicity of B-RAF inhibitors: Exclusively due to UVA radiation and rapidly regressiveRomain Gabeff, Hervé Dutartre, Amir Khammari, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 30, 2015
Dysgeusia and weight loss under treatment with vismodegib: benefit of nutritional managementMarie Le Moigne, Mélanie Saint-Jean, Adam Jirka, et al.
Oncology Reports|June 14, 2014
Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patientsMelanie Saint-Jean, Gaëlle Quereux, Jean-Michel Nguyen, et al.
The Journal of Investigative Dermatology|September 13, 2013
Is a single BRAF wild-type test sufficient to exclude melanoma patients from vemurafenib therapy?Mélanie Saint-Jean, Gaëlle Quéreux, Jean-Michel Nguyen, et al.
Plos One|January 4, 2013
Tissue biomarkers in melanoma patients treated with TILAnne-Chantal Knol, Jean-Michel Nguyen, Marie-Christine Pandolfino, et al.
Acta Dermato-Venereologica|November 22, 2016
Clinical, Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant RecipientsAnabelle Brocard, Anne-Chantal Knol, Céline Bossard, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Dermatology : EJD|November 7, 2013
Severe radiotherapy-induced extracutaneous toxicity under vemurafenibLucie Peuvrel, Anne-Lise Ruellan, François Thillays, et al.
Acta Dermato-Venereologica|May 9, 2014
Vorinostat for refractory or relapsing epidermotropic T-cell lymphoma: a retrospective cohort study of 15 patientsAnne Kogge, Christelle Volteau, Mélanie Saint-Jean, et al.
European Journal of Dermatology : EJD|August 23, 2013
Atypical cutaneous vasculitis under lapatinibLucie Peuvrel, Gaëlle Quereux, Anabelle Brocard, et al.
Journal of the American Academy of Dermatology|September 18, 2013
Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literatureGaelle Quéreux, Anabelle Brocard, Mélanie Saint-Jean, et al.
European Journal of Dermatology : EJD|August 6, 2015
Phototoxicity of B-RAF inhibitors: Exclusively due to UVA radiation and rapidly regressiveRomain Gabeff, Hervé Dutartre, Amir Khammari, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 30, 2015
Dysgeusia and weight loss under treatment with vismodegib: benefit of nutritional managementMarie Le Moigne, Mélanie Saint-Jean, Adam Jirka, et al.
Oncology Reports|June 14, 2014
Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patientsMelanie Saint-Jean, Gaëlle Quereux, Jean-Michel Nguyen, et al.
The Journal of Investigative Dermatology|September 13, 2013
Is a single BRAF wild-type test sufficient to exclude melanoma patients from vemurafenib therapy?Mélanie Saint-Jean, Gaëlle Quéreux, Jean-Michel Nguyen, et al.
Plos One|January 4, 2013
Tissue biomarkers in melanoma patients treated with TILAnne-Chantal Knol, Jean-Michel Nguyen, Marie-Christine Pandolfino, et al.
Acta Dermato-Venereologica|November 22, 2016
Clinical, Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant RecipientsAnabelle Brocard, Anne-Chantal Knol, Céline Bossard, et al.
Pageof 4